feed,title,long_url,short_url
Benzinga,FDA Approves Second Indication for Skyrizi For Active Psoriatic Arthritis,https://benzinga.com/general/biotech/22/01/25179064/fda-approves-second-indication-for-skyrizi-for-active-psoriatic-arthritis,https://bit.ly/3nTjic1
Benzinga,Pfizer - OPKO Health's Growth Hormone Deficiency Candidate Receives FDA Response Letter,https://benzinga.com/general/biotech/22/01/25178945/pfizer-opko-healths-growth-hormone-deficiency-candidate-receives-fda-response-letter,https://bit.ly/3H0S6zK
